COMPANY PROFILE // THE 014 REPORT
Celularity Inc
CELU (Nasdaq) · Formerly: GX Acquisition Corp.
Assembled from 2 government sources in 2.9 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- AmberNT 10-Q filed on 2026-11-16: notice that a periodic report would be late (5 such notices in 24 months).
- Amber9 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-09-29: a pattern of leadership change.
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-07-29 and 3 more times (last 24 months).
✓ SEC filings✓ State registrationpossible match✗ LEI✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no website, no lobbying registration on record.
Celularity Inc is an SEC-registered operating company in pharmaceutical preparations, incorporated in DE, based in Florham Park, NJ; listed as CELU (Nasdaq).[source] It reported revenue of $26.6 million for the fiscal year ended 2025-12-31.[source] It has filed 77 documents with the SEC in the last 12 months; the latest is a NT 10-Q, filed 2026-11-16.[source] Its largest institutional holders on 13F filings are C V STARR & CO INC, VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC (as of 2026-06-30).[source] Seraphix flags 3 items from these records: 8-K Item 3.01 filed; 9 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-09-29; NT 10-Q filed on 2026-11-16.[source]
- red0
- amber3
- info0
- C V STARR & CO INC$1.6M
- VANGUARD CAPITAL MANAGEMENT LLC$371K
- GEODE CAPITAL MANAGEMENT, LLC$100K
- CITADEL ADVISORS LLC$59K
- VANGUARD FIDUCIARY TRUST CO$48K
- BlackRock, Inc.$46K
- STATE STREET CORP$35K
- NORTHERN TRUST CORP$26K
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Beers David C · Chief Financial Officer (Officer) · latest Form 4 2025-04-15 · filing · LinkedIn search
- Brigido Stephen · Pres., Functional Regeneration (Officer) · latest Form 4 2025-04-15 · filing · LinkedIn search
- DosSantos Joseph · Interim CFO (Officer) · latest Form 3 2025-07-16 · filing · LinkedIn search
- Haines John R · Senior Exec Vice President (Officer) · latest Form 4 2025-04-15 · filing · LinkedIn search
- Hariri Robert J · Chief Executive Officer (Director,Officer) · latest Form 4/A 2025-06-04 · filing · LinkedIn search
- Diamandis Peter · Director · latest Form 4/A 2026-01-15 · filing · LinkedIn search
- LeVien Vincent · Director · latest Form 4/A 2026-01-15 · filing · LinkedIn search
- Ling Geoffrey M.D. · Director · latest Form 4/A 2026-01-15 · filing · LinkedIn search
- Parks Diane L. · Director · latest Form 4/A 2026-01-15 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 25 CLEAR, 1 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001752828 | source |
| EIN | 83-1702591 | source |
| Connecticut business ID | 1310320 | record |
| Business address (SEC) | 170 PARK AVE, FLORHAM PARK, NJ, 07932 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; <br>Emerging growth company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; <br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- Cryoport, Inc. · Hariri Robert J
- SOLIGENIX, INC. · Parks Diane L.
- Kura Oncology, Inc. · Parks Diane L.
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-16 filing NT 10-Q · SEC EDGAR
- 2026-11-10 filing ARS · SEC EDGAR
- 2026-11-10 filing DEFA14A · SEC EDGAR
- 2026-11-10 filing Proxy statement · SEC EDGAR
- 2026-10-29 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-10-29 filing PRE 14A · SEC EDGAR
- 2026-10-20 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-10-20 filing 10-K/A · SEC EDGAR
- 2026-09-29 officer change 8-K items 5.02,9.01 · SEC EDGAR
- 2026-09-29 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-09-28 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-09-28 officer change 8-K items 1.01,2.03,3.02,5.02,9.01 · SEC EDGAR
- 2026-09-14 filing 8-K items 8.01 · SEC EDGAR
- 2026-08-14 filing NT 10-Q · SEC EDGAR
- 2026-08-07 officer change 8-K items 5.02 · SEC EDGAR
- 2026-07-29 filing 8-K items 3.01 · SEC EDGAR
- 2026-07-22 filing 25-NSE · SEC EDGAR
- 2026-06-30 officer change 8-K items 1.01,2.03,5.02,9.01 · SEC EDGAR
- 2026-06-25 officer change 8-K items 5.02 · SEC EDGAR
- 2026-06-23 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-06-12 filing 8-K items 3.01 · SEC EDGAR
- 2026-06-03 officer change 8-K items 5.02,7.01,9.01 · SEC EDGAR
- 2026-05-28 filing 8-K items 1.01,2.03,9.01 · SEC EDGAR
- 2026-05-15 filing NT 10-Q · SEC EDGAR
- 2026-04-30 filing Annual report (10-K) · SEC EDGAR
- 2026-04-22 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-04-21 officer change 8-K items 1.01,2.03,3.03,5.02,8.01,9.01 · SEC EDGAR
- 2026-04-03 filing SCHEDULE 13D · SEC EDGAR
- 2026-03-31 filing NT 10-K · SEC EDGAR
- 2026-03-10 filing 8-K items 1.01,8.01,9.01 · SEC EDGAR
170 earlier entries
- 2026-03-05 officer change 8-K items 5.02
- 2026-01-21 officer change 8-K items 5.02
- 2026-01-08 filing 424B3
- 2026-01-07 filing EFFECT
- 2026-01-05 filing CORRESP
- 2026-01-05 filing UPLOAD
- 2025-12-31 filing Registration (S-1)
- 2025-12-30 filing 424B3
- 2025-12-29 filing EFFECT
- 2025-12-23 filing CORRESP
- 2025-12-23 filing 8-K items 1.01,2.03,3.02,8.01,9.01
- 2025-12-23 filing UPLOAD
- 2025-12-19 filing Registration (S-1)
- 2025-12-19 filing 8-K items 5.07
- 2025-12-05 filing 8-K items 8.01
- 2025-11-21 insider First Form 3/4/5 on record for Diamandis Peter (Director)
- 2025-11-21 insider First Form 3/4/5 on record for Ling Geoffrey M.D. (Director)
- 2025-11-21 insider First Form 3/4/5 on record for Parks Diane L. (Director)
- 2025-11-14 filing Quarterly report (10-Q)
- 2025-11-07 filing S-8
- 2025-11-07 filing DEFA14A
- 2025-11-07 filing ARS
- 2025-11-07 filing Proxy statement
- 2025-11-03 filing D
- 2025-10-28 filing 8-K items 1.01,3.02,5.03,9.01
- 2025-09-03 filing 8-K items 8.01
- 2025-08-29 filing Quarterly report (10-Q)
- 2025-08-29 filing Quarterly report (10-Q)
- 2025-08-18 filing 8-K items 1.01,8.01,9.01
- 2025-08-12 filing 8-K items 1.01,8.01,9.01
- 2025-08-05 filing D
- 2025-08-05 filing D
- 2025-08-05 filing D
- 2025-08-01 filing 8-K items 1.01,2.03,3.02,9.01
- 2025-07-30 filing 8-K items 1.01,3.02,9.01
- 2025-07-29 filing 8-K/A items 9.01
- 2025-07-28 filing SCHEDULE 13D/A
- 2025-07-22 filing 8-K items 1.01,3.02,9.01
- 2025-07-16 insider First Form 3/4/5 on record for DosSantos Joseph (Interim CFO)
- 2025-07-10 insider First Form 3/4/5 on record for LeVien Vincent (Director)
- 2025-06-10 officer change 8-K items 5.02,9.01
- 2025-06-06 officer change 8-K items 5.02
- 2025-05-21 filing 10-K/A
- 2025-05-20 filing 8-K items 1.01,3.02
- 2025-05-16 officer change 8-K items 5.02
- 2025-05-09 filing 8-K items 2.02,9.01
- 2025-05-08 filing Annual report (10-K)
- 2025-05-01 filing 8-K items 8.01
- 2025-04-23 filing 8-K items 3.01
- 2025-04-15 insider First Form 3/4/5 on record for Beers David C (Chief Financial Officer)
- 2025-04-15 insider First Form 3/4/5 on record for Brigido Stephen (Pres., Functional Regeneration)
- 2025-04-15 insider First Form 3/4/5 on record for Haines John R (Senior Exec Vice President)
- 2025-04-15 insider First Form 3/4/5 on record for Hariri Robert J (Chief Executive Officer)
- 2025-03-31 filing NT 10-K
- 2025-03-21 filing 8-K items 1.01,3.02,9.01
- 2025-03-10 filing RW
- 2025-02-24 filing 8-K items 8.01,9.01
- 2025-02-18 filing 8-K items 1.01,3.02,9.01
- 2025-02-14 filing EFFECT
- 2025-02-13 filing CORRESP
- 2025-02-13 filing CORRESP
- 2025-02-13 filing FWP
- 2025-02-13 filing S-1/A
- 2025-02-06 filing UPLOAD
- 2025-01-30 filing Registration (S-1)
- 2025-01-28 filing SCHEDULE 13D/A
- 2025-01-27 filing 8-K items 1.01
- 2025-01-24 filing 8-K items 1.02
- 2025-01-03 filing 8-K items 1.01,3.02,9.01
- 2024-12-20 filing 8-K items 5.07
- 2024-12-19 filing SCHEDULE 13D/A
- 2024-12-06 filing Quarterly report (10-Q)
- 2024-12-02 filing 8-K items 1.01,2.03,3.02,9.01
- 2024-11-29 filing 8-K items 3.01
- 2024-11-19 filing Proxy statement
- 2024-11-15 filing NT 10-Q
- 2024-11-08 filing 8-K items 8.01
- 2024-11-07 filing 8-K items 2.02,8.01,9.01
- 2024-11-07 filing Quarterly report (10-Q)
- 2024-10-25 filing 8-K items 2.02,9.01
- 2024-10-21 filing 8-K items 3.01
- 2024-10-16 filing Quarterly report (10-Q)
- 2024-10-16 filing 8-K items 1.01,8.01,9.01
- 2024-09-13 officer change 8-K items 5.02
- 2024-08-28 officer change 8-K items 5.02,7.01,8.01,9.01
- 2024-08-23 filing 8-K items 3.01
- 2024-08-16 filing NT 10-Q
- 2024-08-05 officer change 8-K items 4.01,5.02,9.01
- 2024-07-30 filing Annual report (10-K)
- 2024-05-24 filing 8-K items 3.01
- 2024-05-21 filing 8-K items 2.02,7.01,9.01
- 2024-05-15 filing NT 10-Q
- 2024-04-22 filing 8-K items 3.01
- 2024-04-01 filing NT 10-K
- 2024-03-15 filing SC 13D/A
- 2024-03-15 filing 8-K items 1.01,2.03,3.02,3.03,9.01
- 2024-02-26 filing 8-K items 3.03,5.03,5.07,9.01
- 2024-02-22 officer change 8-K items 5.02,9.01
- 2024-02-12 filing 8-K items 7.01,9.01
- 2024-02-02 filing Proxy statement
- 2024-01-23 filing PRE 14A
- 2024-01-17 filing SC 13D/A
- 2024-01-17 officer change 8-K items 1.01,3.02,5.02,9.01
- 2024-01-09 filing 8-K items 2.02,9.01
- 2024-01-03 filing Quarterly report (10-Q)
- 2023-12-29 officer change 8-K items 5.02
- 2023-11-24 filing 8-K items 3.01
- 2023-11-14 filing NT 10-Q
- 2023-09-19 officer change 8-K items 1.01,3.02,5.02,8.01
- 2023-09-07 officer change 8-K items 5.02,7.01,9.01
- 2023-08-29 filing 8-K items 8.01,9.01
- 2023-08-25 filing 8-K items 1.01,2.03,9.01
- 2023-08-14 filing Quarterly report (10-Q)
- 2023-08-04 officer change 8-K items 5.02
- 2023-07-28 filing 8-K items 1.01,8.01,9.01
- 2023-07-28 filing 424B5
- 2023-06-22 filing SC 13D/A
- 2023-06-21 filing 8-K items 1.01,2.03,3.02,9.01
- 2023-06-16 filing 8-K items 5.03,5.07,9.01
- 2023-06-02 filing EFFECT
- 2023-06-02 filing 424B3
- 2023-05-31 filing 8-K items 8.01,9.01
- 2023-05-31 filing CORRESP
- 2023-05-31 filing UPLOAD
- 2023-05-25 filing S-3
- 2023-05-22 filing Quarterly report (10-Q)
- 2023-05-19 officer change 8-K items 1.01,3.02,5.02,9.01
- 2023-05-16 filing 8-K items 1.01,2.03,9.01
- 2023-05-15 filing NT 10-Q
- 2023-05-01 filing ARS
- 2023-05-01 filing Proxy statement
- 2023-04-27 filing 8-K items 8.01,9.01
- 2023-04-21 filing PRE 14A
- 2023-04-07 filing 424B5
- 2023-04-07 filing 8-K items 1.01,8.01,9.01
- 2023-03-31 filing Annual report (10-K)
- 2023-03-23 filing 8-K items 1.01,2.03,3.02,9.01
- 2023-03-17 filing 8-K items 8.01,9.01
- 2023-03-17 filing 8-K items 3.01
- 2023-03-13 filing 8-K items 7.01
- 2023-01-30 officer change 8-K items 5.02,8.01,9.01
- 2022-12-16 filing 8-K items 8.01
- 2022-11-10 filing Quarterly report (10-Q)
- 2022-11-10 filing 8-K items 2.02,9.01
- 2022-10-06 officer change 8-K items 5.02
- 2022-09-23 officer change 8-K items 5.02
- 2022-09-15 filing 8-K items 1.01,2.03,9.01
- 2022-09-15 filing 424B5
- 2022-09-08 filing 8-K items 1.01,9.01
- 2022-09-08 filing 424B5
- 2022-08-24 filing 424B3
- 2022-08-24 filing 424B3
- 2022-08-23 filing EFFECT
- 2022-08-23 filing EFFECT
- 2022-08-18 filing EFFECT
- 2022-08-16 filing CORRESP
- 2022-08-16 filing UPLOAD
- 2022-08-11 filing S-3
- 2022-08-11 filing POS AM
- 2022-08-11 filing POS AM
- 2022-08-11 filing S-8
- 2022-08-10 filing 424B3
- 2022-08-10 filing 424B3
- 2022-08-10 filing 8-K items 2.02,9.01
- 2022-08-09 filing Quarterly report (10-Q)
- 2022-07-20 filing 424B3
- 2022-07-20 filing 424B3
- 2022-07-20 officer change 8-K items 5.02
- 2022-07-15 filing 10-K/A
- 2022-07-14 filing 424B3
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-16 (within 7 days) NT 10-Q filed
- 2026-11-10 (within 30 days) ARS filed
- 2026-11-10 (within 30 days) DEFA14A filed
- 2026-11-10 (within 30 days) DEF 14A filed
- 2026-10-29 (within 30 days) 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-10-29 (within 30 days) PRE 14A filed
- 2026-10-20 (older) 10-Q filed
- 2026-10-20 (older) 10-K/A filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:CELU The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
6 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1752828 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | CELU / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 831702591 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001752828 | SEC EDGAR / IRS |
| CUSIP | 151190204 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001752828 | SEC EDGAR |
possible match: matched by name only, not merged (2)
Identifiers carried by records that share the company's exact name. Not merged into the identity above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| EPA FRS id | 110071131315 (CELULARITY) | name-exact: exact name match to 'Celularity Inc' (no other entity shares the name) | EPA ECHO facilities |
| EPA FRS id | 110071883565 (CELULARITY INC) | name-exact:legal-name: same registered legal name as 'Celularity Inc' | EPA ECHO facilities |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $26,550,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-20 09:59 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$91,716,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 09:59 UTC | Report an error |
| Total assets (at 2025-12-31) | $107,329,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 09:59 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | -$38,062,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-20 09:59 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $6,175,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 09:59 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 09:59 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 09:59 UTC | Report an error |
| State of incorporation | DE | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 09:59 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 09:59 UTC | Report an error |
| Business address | 170 PARK AVE, FLORHAM PARK, NJ, 07932 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 09:59 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 09:59 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$13,254,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 09:59 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2024-12-31) | $161,000 | 2024-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 09:59 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $26,898,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 09:59 UTC | Report an error |
| Form D total offering amount (D filed 2025-11-03) | $6,666,667 | 2025-11-03 | D | as filed | 2026-11-20 09:59 UTC | Report an error |
| Form D total amount sold (D filed 2025-11-03) | $2,000,000 | 2025-11-03 | D | as filed | 2026-11-20 09:59 UTC | Report an error |
| Form D industry group | Biotechnology | 2025-11-03 | D | as filed | 2026-11-20 09:59 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2025-11-03 | D | as filed | 2026-11-20 09:59 UTC | Report an error |
| Form D date of first sale | 2025-10-24 | 2025-11-03 | D | as filed | 2026-11-20 09:59 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-06-30, filed 2026-10-20 · accession 0001493152-26-047787
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $5,432,000 | 3 months ended 2026-06-30 | 10-Q | 2026-10-20 | 0001493152-26-047787 | 2026-11-20 09:59 UTC | Report an error |
| Net income (loss) | $706,000 | 3 months ended 2026-06-30 | 10-Q | 2026-10-20 | 0001493152-26-047787 | 2026-11-20 09:59 UTC | Report an error |
| Interest expense | $177,000 | 3 months ended 2026-06-30 | 10-Q | 2026-10-20 | 0001493152-26-047787 | 2026-11-20 09:59 UTC | Report an error |
| Cash and cash equivalents | $586,000 | at 2026-06-30 | 10-Q | 2026-10-20 | 0001493152-26-047787 | 2026-11-20 09:59 UTC | Report an error |
| Contract liabilities (total) | $18,200,000 | at 2026-06-30 | 10-Q | 2026-10-20 | 0001493152-26-047787 | 2026-11-20 09:59 UTC | Report an error |
| Contract liabilities, current | $5,130,000 | at 2026-06-30 | 10-Q | 2026-10-20 | 0001493152-26-047787 | 2026-11-20 09:59 UTC | Report an error |
| Contract liabilities, noncurrent | $13,070,000 | at 2026-06-30 | 10-Q | 2026-10-20 | 0001493152-26-047787 | 2026-11-20 09:59 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-16 Filing NT 10-Q filed
- 2026-11-10 Filing ARS filed
- 2026-11-10 Filing DEFA14A filed
- 2026-11-10 Filing DEF 14A filed
- 2026-10-29 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-10-29 Filing PRE 14A filed
- 2026-10-20 Filing 10-Q filed
- 2026-10-20 Filing 10-K/A filed
- 2026-09-29 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-09-29 Filing 10-Q filed
- 2026-09-28 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 3.02 unregistered equity sale; Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-09-14 Filing 8-K filed: Item 8.01 other event
- 2026-08-14 Filing NT 10-Q filed
- 2026-08-07 Filing 8-K filed: Item 5.02 officer or director change
- 2026-07-29 Filing 8-K filed: Item 3.01 delisting notice
- 2026-07-22 Filing 25-NSE filed
- 2026-06-30 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-06-25 Filing 8-K filed: Item 5.02 officer or director change
- 2026-06-12 Filing 8-K filed: Item 3.01 delisting notice
- 2026-06-03 Filing 8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-28 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 9.01 exhibits
- 2026-05-15 Filing NT 10-Q filed
- 2026-04-30 Filing 10-K filed
- 2026-04-21 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 3.03 rights of holders modified; Item 5.02 officer or director change; Item 8.01 other event; Item 9.01 exhibits
- 2026-03-31 Filing NT 10-K filed
POSSIBLE MATCHES · GROUPED BY SOURCE8. Enforcement by agency
EPA ECHO facilities (2)
possible match: matched by name only, not merged (2)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchCELULARITY · exact name match to 'Celularity Inc' (no other entity shares the name) · sx:epa:110071131315 Compare
- possible matchCELULARITY INC · exact legal name · sx:epa:110071883565 Compare
Each record's own page holds its date and the agency document. Matched by exact name only; none of these is counted in the headline.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | C V STARR & CO INC | $1,581,623 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:59 UTC | Report an error |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $371,421 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:59 UTC | Report an error |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | $99,957 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:59 UTC | Report an error |
| 4 | CITADEL ADVISORS LLC | $59,224 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:59 UTC | Report an error |
| 5 | VANGUARD FIDUCIARY TRUST CO | $47,765 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:59 UTC | Report an error |
| 6 | BlackRock, Inc. | $45,655 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:59 UTC | Report an error |
| 7 | STATE STREET CORP | $34,577 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:59 UTC | Report an error |
| 8 | NORTHERN TRUST CORP | $26,405 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:59 UTC | Report an error |
| 9 | Biltmore Family Office, LLC | $20,927 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:59 UTC | Report an error |
| 10 | HB Wealth Management, LLC | $19,082 | 2026-06-30 | SEC 13F filing | 2026-11-20 09:59 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
4 state and city records carry this company's exact name, from 3 sources. Possible matches only.
State licences (2)
possible match: matched by name only, not merged (2)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchCELULARITY, INC. · exact legal name · sx:elic:ctcred:1747001 Compare
- possible matchCelularity, Inc · exact legal name · sx:elic:ctcred:1645801 Compare
Connecticut business registrations (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchCELULARITY INC. · exact legal name · sx:ctsos:1310320 Compare
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchCelularity Incorporated · exact legal name · sx:ctgov:h2cb5f5c2cd3ecf86 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1752828.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001752828. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.